Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Anavex Life Sciences Corp. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 147 | 1 | 141 | −5 |
| Shares | 31.9M | 98.7K | 26.8M | −4.93M (−15.5%) |
| Value | $161.3M | $502.3K | $113.3M | −$47.4M (−29.5%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Anavex Life Sciences Corp. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 94,578 | $399.1K | 0.02% |
| HRT Financial LP | 94,204 | $397.0K | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 81,890 | $345.6K | 0.01% |
| Mirae Asset Global ETFs Holdings Ltd. | 45,866 | $194.1K | 0.00% |
| Squarepoint Ops LLC | 45,352 | $191.4K | 0.00% |
| Marshall Wace, LLP | 39,351 | $166.1K | 0.00% |
| Corebridge Financial, Inc. | 39,163 | $165.3K | 0.00% |
| Dynamic Technology Lab Private Ltd | 29,294 | $124.0K | 0.01% |
| Brevan Howard Capital Management LP | 25,801 | $108.9K | 0.01% |
| Catalyst Funds Management Pty Ltd | 18,600 | $78.5K | 0.02% |
| SG Americas Securities, LLC | 13,434 | $57.0K | 0.00% |
| Inceptionr LLC | 10,971 | $46.3K | 0.01% |
| Man Group plc | 10,685 | $45.1K | 0.00% |
| Activest Wealth Management | 4,001 | $16.9K | 0.01% |
| Allspring Global Investments Holdings, LLC | 2,152 | $9.08K | 0.00% |
| Quadrant Capital Group LLC | 1,512 | $6.38K | 0.00% |
| Cypress Capital, LLC | 700 | $2.95K | 0.00% |
| Parallel Advisors, LLC | 250 | $1.05K | 0.00% |
| Jones Financial Companies LLLP | 200 | $844 | 0.00% |
| Rothschild Investment LLC | 60 | $253 | 0.00% |
| Smartleaf Asset Management LLC | 56 | $240 | 0.00% |
Sold out (26)
Institutions that held Anavex Life Sciences Corp. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Anavex Life Sciences Corp. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 98,689 | $502.3K |